Orthofix Medical Receives US FDA’s 510(k) clearance & European CE Mark for its TrueLok Elevate Transverse Bone Transport (TBT) System
Shots:
- Orthofix Medical has reported US FDA’s 510(k) clearance & European CE Mark for its TrueLok Elevate Transverse Bone Transport (TBT) System for limb preservation; available in limited market release in the US & select international markets
- TrueLok Elevate offers limb preservation solution for treating bony or soft tissue deformities & defects, incl. diabetic foot ulcers (DFU) as well as chronic or deep tissue wounds, with clinical studies showing reduced amputation risk, improved blood circulation & enhanced wound healing in DFU
- TrueLok Elevate also allows surgeons to create a tibial bone segment that is gradually distracted over days, with first pts cases performed in the UK & Germany
Ref: Businesswire | Image: Orthofix
Related News:- Orthofix Medical Reports the US FDA’s Clearance of Fitbone Transport and Lengthening System
PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com
Click here to read the full press release
Tags
Ridhi is an avid secondary researcher who follows trends in the biopharmaceutical and healthcare sectors to curate engaging content for the global audience. She works as a news editor at PharmaShots and loves to read books and explore new destinations.
